
In November 2022, the global population had officially crossed eight billion. It has long been recognized that socioeconomic or health-related problems in the community always accompany an uncontrolled population expansion. International calls have been made regarding lack of universal health coverage, an insufficient supply of healthcare providers, the burden of noncommunicable disease, population aging and the difficulty in obtaining safe drinking water and food. The present health policy paper discusses how to conquer these crowded world issues, including (1) promoting government and international organization participation in providing appropriate infrastructure, funding and distribution to assist people's health and well-being; (2) shifting health program towards a more preventive approach and (3) reducing inequalities, particularly for the marginalized, isolated and underrepresented population. These fundamental principles of health policy delivery as a response to an increasingly crowded world and its challenges are crucial for reducing the burden associated with excessive healthcare costs, decreased productivity and deteriorating environmental quality.
Citation: Nityanand Jain, Islam Kourampi, Tungki Pratama Umar, Zahra Rose Almansoor, Ayush Anand, Mohammad Ebad Ur Rehman, Shivani Jain, Aigars Reinis. Global population surpasses eight billion: Are we ready for the next billion?[J]. AIMS Public Health, 2023, 10(4): 849-866. doi: 10.3934/publichealth.2023056
[1] | Andreas Widder, Christian Kuehn . Heterogeneous population dynamics and scaling laws near epidemic outbreaks. Mathematical Biosciences and Engineering, 2016, 13(5): 1093-1118. doi: 10.3934/mbe.2016032 |
[2] | Yicang Zhou, Zhien Ma . Global stability of a class of discrete age-structured SIS models with immigration. Mathematical Biosciences and Engineering, 2009, 6(2): 409-425. doi: 10.3934/mbe.2009.6.409 |
[3] | Marcin Choiński . An inherently discrete–time SIS model based on the mass action law for a heterogeneous population. Mathematical Biosciences and Engineering, 2024, 21(12): 7740-7759. doi: 10.3934/mbe.2024340 |
[4] | Peter Rashkov, Ezio Venturino, Maira Aguiar, Nico Stollenwerk, Bob W. Kooi . On the role of vector modeling in a minimalistic epidemic model. Mathematical Biosciences and Engineering, 2019, 16(5): 4314-4338. doi: 10.3934/mbe.2019215 |
[5] | Joan Ponce, Horst R. Thieme . Can infectious diseases eradicate host species? The effect of infection-age structure. Mathematical Biosciences and Engineering, 2023, 20(10): 18717-18760. doi: 10.3934/mbe.2023830 |
[6] | Xiaowei An, Xianfa Song . A spatial SIS model in heterogeneous environments with vary advective rate. Mathematical Biosciences and Engineering, 2021, 18(5): 5449-5477. doi: 10.3934/mbe.2021276 |
[7] | Marcin Choiński, Mariusz Bodzioch, Urszula Foryś . A non-standard discretized SIS model of epidemics. Mathematical Biosciences and Engineering, 2022, 19(1): 115-133. doi: 10.3934/mbe.2022006 |
[8] | Philip K. Pollett . An SIS epidemic model with individual variation. Mathematical Biosciences and Engineering, 2024, 21(4): 5446-5455. doi: 10.3934/mbe.2024240 |
[9] | Zhen Jin, Guiquan Sun, Huaiping Zhu . Epidemic models for complex networks with demographics. Mathematical Biosciences and Engineering, 2014, 11(6): 1295-1317. doi: 10.3934/mbe.2014.11.1295 |
[10] | Jinzhe Suo, Bo Li . Analysis on a diffusive SIS epidemic system with linear source and frequency-dependent incidence function in a heterogeneous environment. Mathematical Biosciences and Engineering, 2020, 17(1): 418-441. doi: 10.3934/mbe.2020023 |
In November 2022, the global population had officially crossed eight billion. It has long been recognized that socioeconomic or health-related problems in the community always accompany an uncontrolled population expansion. International calls have been made regarding lack of universal health coverage, an insufficient supply of healthcare providers, the burden of noncommunicable disease, population aging and the difficulty in obtaining safe drinking water and food. The present health policy paper discusses how to conquer these crowded world issues, including (1) promoting government and international organization participation in providing appropriate infrastructure, funding and distribution to assist people's health and well-being; (2) shifting health program towards a more preventive approach and (3) reducing inequalities, particularly for the marginalized, isolated and underrepresented population. These fundamental principles of health policy delivery as a response to an increasingly crowded world and its challenges are crucial for reducing the burden associated with excessive healthcare costs, decreased productivity and deteriorating environmental quality.
There is a large number of papers with mathematical models of epidemic dynamics. These papers relate to both homogeneous and heterogeneous populations. By heterogeneous population we understand a population with at least two subpopulations that differ in the risk of getting infected. Because of convenience and lack of appropriate data, only two subpopulations are often distinguished. In recent papers [1] and [2], one can find exemplary models of epidemic spread in such populations with mathematical analysis.
Nowadays, the risk of co-infections is increasing worldwide, including co-infections with COVID-19 [3]. This increase is caused by, for example, increased people's mobility [4], drug resistance [5], impaired immunity after suffering from long COVID-19, and reduction of exposure to microbiota caused by home isolation during the COVID-19 pandemic [6]. Also, getting an infection raises the probability of simultaneous development of another illness [7]. Co-infection also boosts healthcare costs [8] and number of deaths [9]. It is therefore essential to put an effort into reducing co-infection cases. This reduction can be achieved by applying mathematical modeling. Thanks to mathematical models of co-infection spreading and their mathematical analysis, one can predict co-infections and implement proper therapeutic approaches. This is desirable since data concerning co-infections are less accessible than for single epidemics.
Generally, models of co-infection dynamics are based on models that describe the spread of a single epidemic. Hence, they have a more complex form and are, consequently, more difficult to analyze. However, one can find literature dealing with mathematical analysis of co-infection spread. A recent paper [10] conducted a systemic review of mathematical models. A model of general co-infection for an acute and a chronic disease was presented in [11]. The authors in [12] proposed and analyzed the model of COVID-19 and tuberculosis (TB) infection. The same type of epidemics, together with measuring impact on isolation, was investigated in [13]. Papers [14] and [15] provide mathematical models for the spread of SARS-CoV-2 with hepatitis B virus and SARS-CoV-2 with human T-cell lymphotropic virus type-I, respectively. The analysis of models concerning individuals suffering from COVID-19 and kidney disease was presented in a recent work [16]. An interesting approach is presented in [17], where the authors investigated the co-infection of airborne and vector-host diseases, namely COVID-19 and dengue.
Not only COVID-19 is investigated in co-infection modeling. Since HIV infection increases the probability of developing TB [18], papers related to the modeling of TB and HIV spread contribute significantly to the literature. Authors in [19] distinguish two TB infected classes: fast and slow latent. They also considered acute and chronic HIV-infected groups. A recent paper [20] focused on an analysis of a TB/HIV epidemic spread in Ethiopia, with two infected groups for each disease. Naturally, other co-infections are also analyzed in the literature. Authors in [21] investigated the epidemic of HIV and hepatitis C virus, whereas paper [22] dealt with co-infection of TB and pneumonia.
In each paper described above, authors assumed that there is only one class of people that are not infected with any disease; this means they are susceptible to both infections. This leads to situations where the probability of co-infection is raised only by encountering a single infection. That supposition implies no population heterogeneity for healthy individuals. Clearly, this case is not valid. Therefore, there is a need to include heterogeneity in a susceptible class. While modeling an epidemic of a single infection for a heterogeneous population, authors assume that values of parameters reflecting a given subpopulation are the same. This assumption actually leads to the case of a homogeneous population. To adequately describe the dynamics of infection, and consequently of co-infection, in a heterogeneous population, one must consider different values of parameters for each subpopulation. Such consideration makes the mathematical analysis of the model more difficult; thus, this approach is uncommon.
Our paper aims to construct and analyze the mathematical models of co-infection in a heterogeneous population consisting of two subpopulations. We assume that parameter values reflecting a given process in each subpopulation differ. This assumption and the heterogeneity in the population make our paper novel among the literature considering the modeling of co-infections. In our model, we also introduce a case of a spread of each disease not only among one subpopulation but also between subpopulations. This introduction enables our system to be classified as a criss-cross model. We propose a system of ordinary differential equations that is a SIS-type (susceptible – infected – susceptible) model. In models of such type, there is no immunity after recovery and an individual becomes susceptible again. Including heterogeneity constrains computations. For this reason, we do not incorporate a recovered class to maintain explicit results of the analysis. Our model does not relate to particular diseases. Hence, one can apply the obtained results to different infections. Such applications include co-infections that combine sole airborne illnesses, such as TB, COVID-19, or influenza, sexually transmitted diseases, such as gonorrhea, HIV, and hepatitis B, or incorporate illnesses from both types.
This paper is a continuation of our work from [23] and [24], in which we investigated the criss-cross model of epidemic spread of a single disease for a heterogeneous population. In [23], we conducted the mathematical analysis of the model that was proposed in [25]. The aim of that analysis was to confirm, from a mathematical point of view, the medical hypothesis that stated that to control the epidemic spread in the heterogeneous population, one must consider criss-cross illness transmission. Investigating such spread in a single subpopulation does not provide complete insight into the epidemic dynamics. Because of the proposed model's unexpected properties, such as a possible unbounded population growth, we modified the system from [23] by assuming a constant inflow into each subpopulation. We analyzed that modified system in [24] and again obtained consistency with the medical hypothesis. Considering that the second disease in epidemic dynamics for a heterogeneous population is medically driven by an increasing number of co-infections worldwide and different scenarios regarding individuals' susceptibility can provide mathematical results that can help predict a co-infection course.
In [23] and [24], we focused on the stability analysis; we indicated stationary states appearing in the given systems and determined the conditions for their local stability. In this paper, we also apply this approach. The model presented herein relies on the system from [24].
The paper is organized as follows: In Section 2, we describe and introduce our model. Then we find stationary states of the system and describe conditions for their existence. The basic reproduction number of the model is computed in Section 4. The following section deals with local stability of the found stationary state. We summarize our results in Section 7.
Let us first describe the assumptions concerning the proposed model. In a population, we indicate two subpopulations, a low-risk (LS) and a high-risk (HS) subpopulation, relating to the risk of getting infected. LS and HS have, respectively, lower and higher susceptibility to each disease. For every variable and parameter, we assign a subscript i equal to 1 and 2 for LS and HS respectively. If i has no assigned value, then i∈{1,2}. By S1 and S2, we denote a density of healthy people in LS and HS, respectively. The variables Ii refer to the density of individuals from the given subpopulation that are infected by a pathogen of the disease that we call disease A (DA). Similarly, we define Ji as the density of individuals suffering from disease B (DB). The density of a group infected by pathogens from both diseases is denoted by Ki.
Migrating and newborn individuals join each subpopulation through Si class with a recruitment rate Ci. A natural death rate for each subpopulation is equal to μi. For DA, we introduce the transmission rates β11, β22, β12 and β21, reflecting transmission among LS, among HS, from HS to LS, and from LS to HS, respectively. These four different rates mean that DA differs in spreading and contracting a pathogen. To get a preliminary insight on co-infection dynamics for the heterogeneous population, for DB we assume that individuals differ only in contracting a pathogen. For this reason, we take only two transmission coefficients for DB: σ1 for LS and σ2 for HS. By γi and gi, we denote the recovery rate for DA and DB, respectively. The disease-mortality rate for DA and DB is depicted by αi and ai.
The proposed model of co-infection is
˙S1=C1−β11S1I1−β12S1I2+γ1I1−μ1S1−σ1S1(J1+J2)+g1J1, | (2.1a) |
˙I1=β11S1I1+β12S1I2−(γ1+α1+μ1)I1−σ1I1(J1+J2)+g1K1, | (2.1b) |
˙J1=σ1S1(J1+J2)−(g1+a1+μ1)J1−β11J1I1−β12J1I2+γ1K1, | (2.1c) |
˙K1=σ1I1(J1+J2)+β11J1I1+β12J1I2−(g1+a1+γ1+α1+μ1)K1, | (2.1d) |
˙S2=C2−β22S2I2−β21S2I1+γ2I2−μ2S2−σ2S2(J1+J2)+g2J2, | (2.1e) |
˙I2=β22S2I2+β21S2I1−(γ2+α2+μ2)I2−σ2I2(J1+J2)+g2K2, | (2.1f) |
˙J2=σ2S2(J1+J2)−(g2+a2+μ2)J2−β22J2I2−β21J2I1+γ2K2, | (2.1g) |
˙K2=σ2I2(J1+J2)+β22J2I2+β21J2I1−(g2+a2+γ2+α2+μ2)K2. | (2.1h) |
Each parameter is fixed and positive. In particular, every parameter besides Ci is in the range (0,1). If we assume that σi,gi,ai=0, the above system would reduce to the system that we introduced and analyzed in [24].
Figure 1 is a schematic drawing of the proposed model.
In order to make the form of system (2.1) more transparent, we define:
ki:=γi+αi+μi,qi:=gi+ai+μi,ri:=gi+ai+γi+αi+μi. | (2.2) |
Now we indicate the basic properties of the model. The form of the right-hand side of system (2.1) implies that its solutions exist and are unique and positive for any positive initial condition. Let us introduce a variable Ni:=Si+Ii+Ji+Ki that naturally means a density of the whole HS or LS. After adding both sides of Eqs (2.1a)–(2.1d) or Eqs (2.1e)–(2.1h), we get
˙Ni=˙Si+˙Ii+˙Ji+˙Ki=Ci−μiNi−αiIi−aiJi−(αi+ai)Ki. | (2.3) |
See that we can estimate Eq (2.3) from above by the inequality
˙Ni≤Ci−μiNi, | (2.4) |
which solution is
Ni(t)≤(Ni(0)−Ciμi)e−μit+Ciμi. |
For Ni(0)>Ciμi, we observe a decrease of the population. Clearly, we have
Si(t),Ii(t),Ji(t),Ki(t)≤Ni(t)≤Ni(0). |
For Ni(0)<Ciμi, we have a limited growth of the population, since
Si(t),Ii(t),Ji(t),Ki(t)≤Ni(t)≤−˜Ce−μit+Ciμi≤Ciμi, |
where ˜C is any positive constant.
Now we estimate Eq (2.3) by
˙Ni≥Ci−(μi+αi+ai)Ni. | (2.5) |
Combining inequalities (2.4) and (2.5), we get
Ci−(μi+αi+ai)Ni≤˙Ni≤Ci−μiNi, |
which produces the invariant set
Ω:{(S1,I1,J1,K1,S2,I2,J2,K2):Si+Ii+Ji+Ki∈[Ciμi+αi+ai,Ciμi]}. |
This set attracts all solutions of system (2.1). We therefore conclude that the variables Si(t), Ii(t), Ji(t), and Ki(t) are defined for every t>0.
In this section, we indicate stationary states of system (2.1) and determine conditions for their existence.
Firstly, we find stationary states that are not endemic, meaning that at least one of their coordinates equals zero.
We consider separated cases.
1) Firstly, let us assume that Ii=Ji=Ki=0. We immediately get the form of the disease-free stationary state:
Edf=(ˆS1,0,0,0,ˆS2,0,0,0),whereˆS1=C1μ1,ˆS2=C2μ2. | (3.1) |
Clearly, this state always exists.
2) Now, consider the case Ki=0. Without loss of generality, we take K1=0. From Eq (2.1d) for any stationary, state we have 0=σ1I1(J1+J2)+β11J1I1+β12J1I2, which implies
(I1=0∨J1+J2=0)∧(J1=0∨I1=0)∧(J1=0∨I2=0). | (3.2) |
Let us consider the first alternative from (3.2).
a) We first take I1=0. From Eq (2.1b), we have β12S1I2=0, which yields S1=0 or I2=0. If S1=0, then Eq (2.1b) gives the contradiction 0=C1+g1J1. If I2=0, then from Eq (2.1h) we have K2=0 and our system reduces to:
˙Si=0=Ci−μiSi−σiSi(J1+J2)+giJi,˙Ji=0=σiSi(J1+J2)−qiJi. | (3.3) |
The above system's form suggests that there is a stationary state with present DB and absent DA. We will investigate the existence of such postulated state later. System (3.3) fulfills the case I1=0∧I1=0∧I2=0 from (3.2).
Now, assume that I1=0∧J1=0∧J1=0 holds. Then from Eq (2.1b), we get β11S1I2+g1K1=0. It provides S1=0 or I2=0. Case S1=0 linked to Eq (2.1a) yields the contrary, 0=C1, hence we must have I2=0. Then from Eqs (2.1c) and (2.1h), we get J2=0 and K2=0, respectively. We obtain state Edf.
It is easy to check that the case I1=0∧J1=0∧I2=0 gives Edf as well. The case I1=0∧I1=0∧J1=0 is equivalent to I1=0∧J1=0∧J1=0.
b) Now assume that J1+J2=0. This assumption obviously provides J1=0 and J2=0. From Eq (2.1g), we get ˙J2=γ2K2, giving K2=0. We obtain the system
˙Si=0=Ci−βiiSiIi−βijSiIj+γiIi−μiSi,˙Ii=0=βiiSiIi+βijSiIj−kiIi, | (3.4) |
where j=3−i. The above system fulfills condition J1+J2=0∧J1=0∧J1=0, emerged from (3.2).
If we take J1+J2=0 and simultaneously one of the cases J1=0∧I2=0, I1=0∧J1=0 or I1=0∧I2=0, then we obtain Edf.
3) Now suppose that I1=0. From Eq (2.1b), we get 0=β12S1I2+g1K1. From S1I2=0, we get I2=0, which gives system (3.3). Choosing K1=0 leads to system (3.4).
4) Consider J1=0. Then Eq (2.1c) yields 0=σ1S1J2+γ1K1. Both cases J2=0 and K1=0 provide system (3.4).
5) Assuming I1=0∧J1=0 leads to state Edf.
6) Supposing I1=0∧K1=0 and J1=0∧K1=0 results in systems (3.3) and (3.4), respectively.
Reasoning from points 1)–6) conducted for the variables with subscript 2 gives the same conclusions.
System (3.4) appears in our previous paper [24]. The solution of this system provides the endemic state E∗=(S∗1,I∗1,S∗2,I∗2). This state is the projection of the state
EA=(S∗1,I∗1,0,0,S∗2,I∗2,0,0),S∗i,I∗i>0, | (3.5) |
onto the non-negative subspace (S1,I1,S2,I2)∈R4. State EA reflects the presence of DA and the absence of DB. Observe that adding both sides of Eqs (2.1a)–(2.1b) and Eqs (2.1e)–(2.1f) for EA yields 0=Ci−μi(Ii+Si)−αiIi, providing
Ii=Ci−μiSiμi+αi. | (3.6) |
Relying on results for state E∗ from [24], we formulate conditions for the existence of state EA.
Proposition 1. In System (2.1), there exists the stationary state EA defined in (3.5) that reflects the presence of disease A and the absence of disease B. This state exists if at least one of three cases holds:
1) β11C1≥μ1k1;
2) β22C2≥μ2k2;
3) βiiCi<μiki and
(μ1k1−β11C1)(μ2k2−β22C2)≤β12β21C1C2. | (3.7) |
For EA, we have
0<S∗i<kiβii,max(0,βiiCi−μikiμi+αi)<I∗i<βiiCiμi+αi. |
Now we focus on system (3.3). Equation (2.3), being the sum of equations from this system, simplifies to ˙Ni=0=Ci−μiSi−(μi+ai)Ji, which gives
Si=Ci−(μi+ai)Jiμi. | (3.8) |
Computations concerning this system indicate the expected stationary state. Observe that the structure of system (3.3) is analogous to the structure of system (3.4). Based on this analogousness and Proposition 1, we formulate the following proposition concerning the other stationary state.
Proposition 2. In System (2.1), there exists the stationary state
EB:=(ˉS1,0,ˉJ1,0,ˉS2,0,ˉJ2,0),ˉSi,ˉJi>0, | (3.9) |
with present disease B and absent disease A. This state exists if at least one of three cases holds:
1) σ1C1≥μ1q1;
2) σ2C2≥μ2q2;
3) σiCi<μiqi and
σ1C1μ1q1+σ2C2μ2q2≥1. | (3.10) |
For EB, we have
0<ˉSi<qiβii,max(0,σiCi−μiqiμi+ai)<ˉIi<σiCiμi+ai. |
Now we investigate the endemic stationary state, reflecting the presence of both diseases A and B. Since it is difficult to obtain its explicit form, we limit our investigation to indicate some properties concerning its existence. Let us define Zi:=Ii+JI+Ki. Obviously, variable Zi is the density of individuals from the particular subpopulation infected by disease A, B, or both. Summing both sides of Eqs (2.1b)–(2.1d) gives
˙Z1=β11I1S1+β12I2S1−g1J1−a1(J1+K1)+σ1S1(J1+J2)−γ1I1−μ1Z1−α1(I1+K1). |
From the above equation for the postulated endemic state, we have
S1=g1J1+a1(J1+K1)+γ1I1+μ1Z1+α1(I1+K1)β11I1+β12I2+σ1(J1+J2). | (3.11) |
Equation (2.3) and definition of N1 for this state yield
S1=1μ1(C1−μ1(I1+J1+K1)−α1I1−a1J1−(α1+a1)K1). | (3.12) |
Since S1>0, one must fulfill
C1>μ1(I1+J1+K1)+α1I1+a1J1+(α1+a1)K1. |
Combining reorganized Eqs (3.12) and (3.11), we get
(C1−μ1(I1+J1)−α1I1−a1J1−s1K1)(β11I1+β12I2+σ1(J1+J2))=μ1(k1I1+w1J1+s1K1), | (3.13) |
where s1:=α1+a1+μ1 and w1:=g1+a1+μ1.
From Eqs (2.1a)–(2.1d), we get the formula for coordinates S1,I1,J1,K1:
S1=C1+g1J1+γ1I1β11I1+β12I2+μ1+σ1(J1+J2), | (3.14a) |
I1=β12S1I2+g1K1σ1(J1+J2)+k1I1−β11S1, | (3.14b) |
J1=σ1S1J2+γ1K1q1+β11I1+β12I2−σ1S1 | (3.14c) |
K1=β11I1J1+β12J1I2+σ1I1(J1+J2)r1. | (3.14d) |
Positivity of coordinates I1 and J1 yields inequalities:
S1<σ1(J1+J2)+k1I1β11,S1<q1+β11I1+β12I2σ1. |
Combining the above dependences with condition (3.14a), we get
C1<min(σ1(J1+J2)+k1I1β11,q1+β11I1+β12I2σ1)(σ1(J1+J2)+μ1+β11I1+β12I2)−γ1I1−g1J1. |
If we substitute Eq (3.14d) into the above inequality, we get
C1>μ1(I1+J1)+α1I1+a1J1+α1+a1+μ1r1(β11I1J1+β12J1I2+σ1I1(J1+J2)). |
Observe that the reasoning presented in this subsection can be applied to variables with subscript 2. This application provides another condition for the existence of the postulated endemic state.
In this section, we find and investigate the basic reproduction number R0 of system (2.1). According to the definition from [26], R0 refers to the number of new infections produced by a single infectious individual in a population at a disease-free stationary state. To compute R0, we will rely on the next generation method described in [26]. In this section, we provide a sketch of computations leading to the formula for R0. We consider the subsystem of system (2.1), including the equations only for infected variables:
[˙I1,˙J1,˙K1,˙I2,˙J2,˙K2]T=F−V, |
where vector F concerns the terms related to new infections, and vector V reflects the remaining processes. These vectors read
F=[β11S1I1+β12S1I2σ1S1(J1+J2)σ1I1(J1+J2)+β11J1I1+β12J1I2β22S2I2+β21S2I1σ2S2(J1+J2)b2I2(J1+J2)+β22J2I2+β12J2I1],V=[k1I1+σ1I1(J1+J2)−g1K1q1J1+β11J1I1+β12J1I2−γ1K1r1K1k2I2+σ2I1(J1+J2)−g2K2q2J2+β22J2I2+β21J2I1−γ2K2r2K2], |
respectively. We construct matrices F and V that are the Jacobian matrices of F and V evaluated at Edf. These matrices have the form
F=[β11ˆS1β12ˆS10000β21ˆS2β22ˆS2000000σ1ˆS1σ1ˆS10000σ2ˆS2σ2ˆS200000000000000],V=[k1000−g100k2000−g200q10−γ10000q20−γ20000r1000000r2], |
Then we compute FV−1 and obtain
FV−1=[β11k1ˆS1β12k2ˆS100g1β11k1r1ˆS1g2β12k2r2ˆS1β21k1S2β22k2ˆS200g1β21k1r1ˆS2g2β22k2r2ˆS200σ1q1ˆS1σ1q2ˆS1γ1σ1q1r1ˆS1γ2σ1q2r2ˆS100σ2q1ˆS2σ2q2ˆS2γ1σ2q1r1ˆS2γ2σ2q2r2ˆS2000000000000]. |
The basic reproduction number is the spectral radius of the matrix FV−1. The eigenvalues of this read λ1,2,3=0,λ4=σ1q1ˆS1+σ2q2ˆS2, and
λ5,6=12k1k2(k2β11ˆS1+k1β22ˆS2∓√(k2β11ˆS1−k1β22ˆS2)2+4k1k2β12β21ˆS1ˆS2) |
We finally get
R0=max(λ4,λ6). |
See that λ4 consists of terms relying to only infection B, whereas λ6 refers only to infection A.
Now we formulate the theorem relied on the dependence between λ4 and λ6.
Theorem 4.1. R0=λ4 if
ˆS1ˆS2(β12β21−β11β12)<ˆS1ˆS2(σ1u2q1+σ2u1q2)+σ1u1q1ˆS21+σ2u2q2ˆS22, | (4.1) |
where
ui:=k3−i(kiσiqi−βii), | (4.2) |
and
ˆS1(2σ1q1−k2β11)+ˆS2(2σ2q2−k1β22)>0. | (4.3) |
Proof. Observe that λ4>λ6 if
√(k2β11ˆS1−k1β22ˆS2)2+4k1k2β12β21ˆS1ˆS2<2λ4k1k2−k2β11ˆS1−k1β22ˆS2. | (4.4) |
Under fulfillment of
2λ4k1k2>k2β11ˆS1+k1β22ˆS2 | (4.5) |
we raise both sides of inequality (4.4) to the square and transform the result to
ˆS1ˆS2(β12β21−β11β12)<λ4(λ4−k2β11ˆS1−k1β22ˆS2). |
Using the definition of λ4 in the above inequality and transforming the obtained expression, we get
ˆS1ˆS2(β12β21−β11β12)<(σ1ˆS1q1+σ2ˆS2q2)(ˆS1u1+ˆS2u2), | (4.6) |
where ui is defined by Eq (4.2). We rewrite inequality (4.6) as inequality (4.1). Inequality (4.5) with the definition of λ4 can be transformed into inequality (4.3).
Let us strengthen the assumptions from Theorem 4.1 so that we obtain more explicit ones. Suppose that ui>0, which can be written as
βiiqi<kiσi. | (4.7) |
Then condition
σ1u2q1+σ2u1q2>β12β21−β11β12 | (4.8) |
suffices fulfillment of inequality (4.1). Moreover, if
βiiqi<2σik3−i, | (4.9) |
then inequality (4.3) is always true. Combining inequalities (4.7) and (4.9) yields
βiiqi<max(kiσi,2σik3−i). | (4.10) |
We conclude that
Corollary 1. If inequality (4.10), then R0=λ4.
The above corollary confirms the obvious dependence that if the transmission of infection B, represented by σi, is sufficiently stronger than the transmission of infection A between different subpopulations, reflected by βii, then infection B plays a bigger role in the whole population.
Observe that if in inequality (4.3) we replace sign > by sign <, then λ4<λ6. It yields R0=λ6, which is the same as R0 for the system with one infection from [24].
From a medical point of view, the desirable situation is when R0<1. Let us check when this case holds. We formulate the theorem
Theorem 4.2. For system (2.1) R0<1 if
σ1q1ˆS1+σ2q2ˆS2<1, | (4.11) |
ˆSi<kiβii | (4.12) |
and
β12β21ˆS1ˆS2<(β11ˆS1−k1)(β22S2−k2). | (4.13) |
Proof. Condition (4.11) is obvious from the definition of λ4. The part of the proof related to λ6 is similar to the proof of Theorem 4.1. The inequality λ6<1 can be transformed into
√(k2β11ˆS1−k1β22ˆS2)2+4k1k2β12β21ˆS1ˆS2<2k1k2−(k2β11ˆS1+k1β22ˆS2). | (4.14) |
Under condition
2>β11k1ˆS1+β22k2ˆS2 | (4.15) |
multiplying both sides of inequality (4.14) yields
β12β21ˆS1ˆS2<k1k2−k2β11ˆS1−k1β22ˆS2+β11β12ˆS1ˆS2, |
which can be written as inequality (4.13). The right-hand side of inequality (4.13) must be positive. It is true when ˆSi>kiβii or (4.12). The first case is contrary to inequality (4.15). Hence, inequality (4.12) must hold, which is stronger than inequality (4.15).
If is easy to check that inequality (4.13) is opposite to inequality (3.7) from Preposition 1 discussing the existence of state EA. Similarly, inequality (4.11) is opposite to inequality (3.10) from Preposition 2 providing conditions for the EB existence.
Now we investigate the local stability of states Edf, EA, and EB. The Jacobian matrix of system (2.1) can be written as J=(M1M2), where
M1=(G1−β11S1+γ1−σ1S1+g10F1β11S1−k1−σ1(J1+J2)−σ1I1g1σ1(J1+J2)−β11J1σ1S1−q1−F1γ10σ1(J1+J2)+β11J1σ1I1+F1−r10−β21S2−σ2S200β21S2−σ2I200−β21J2−σ2S200β21J2σ2I20), |
and
M2=(0−β12S1−σ1S100β12S1−σ1I100−β12J1σ1S100β12J1σ1I10G2−β22S2+γ2−σ2S2+g20F2β22S2−k2−σ2(J1+J2)−σ2I2g2σ2(J1+J2)−β22J2σ2S2−q2−F2γ20σ2(J1+J2)+β22J2σ2I2+F2−r2) |
with
Fi:=Fi(I1,I2)=βiiIi+βijIj,Gi:=Gi(I1,I2,J1,J2)=−Fi−μi−σi(J1+J2),j=3−i. |
We start from the local stability of Edf.
Theorem 5.1. Edf is locally stable if R0<1.
Proof. The Jacobian matrix for state Edf reads
(−μ1−β11ˆS1+γ1−σ1ˆS1+g100−β12ˆS1−σ1ˆS100β11ˆS1−k10g10β12ˆS10000σ1ˆS1−q1γ100σ1ˆS10000−r100000−β21ˆS2−σ2ˆS20−μ2−β22ˆS2+γ2−σ2ˆS2+g200β21ˆS2000β22ˆS2−k20g200−σ2ˆS2000σ2ˆS2−q2γ20000000−r2). |
Immediately, we get four negative eigenvalues: −μ1, −μ2, −r1, −r2. The remaining eigenvalues are the zeros of the characteristic polynomial of the matrix:
(β11ˆS1−k10β12ˆS100σ1ˆS1−q10σ1ˆS1β21ˆS20β22ˆS2−k200−σ2ˆS20σ2ˆS2−q2). |
This polynomial reads P(λ)=P1(λ)P2(λ), where
P1(λ)=λ2−(β11ˆS1−k1+β22ˆS2−k2)λ+(β11ˆS1−k1)(β22S2−k2)−β12β21ˆS1ˆS2,P2(λ)=λ2−(σ1ˆS1−q1+σ2ˆS2−q2)λ+(σ1ˆS1−q1)(σ2ˆS2−q2)−σ1σ2ˆS1ˆS2. |
It is easy to check that their discriminants are positive. The zeros of P1 are negative if inequalities (4.12) and (4.13) hold. Analogously, P2 has negative zeros if
σ1ˆS1−q1+σ2S2−q2<0 | (5.1) |
and
(σ1ˆS1−q1)(σ2ˆS2−q2)>σ1σ2ˆS1ˆS2. | (5.2) |
Inequality (5.2) can be transformed into inequality (4.11). According to Theorem 4.2, merging inequality (4.11)–(4.13) yields R0<1. Inequality (5.2) yields two exclusive possibilities: σiˆSi>qi or
σiˆSi<qi. | (5.3) |
The first case is contrary to inequality (5.1), whereas inequality (5.3), under condition (5.2), yields inequality (5.1). Hence, we replace inequality (5.1) by inequality (5.3). We rewrite inequality (5.3) as
ˆSi<qiσi. |
Observe that the above inequality is weaker than inequality (4.11); hence, it is omitted in the thesis of Theorem 5.1.
Theorem 5.1 is in line with the analogical result from [24], where we also obtained the local stability of the given disease-free stationary for the basic reproduction number smaller than one.
Now we provide a theorem guaranteeing the local stability of state EA.
Theorem 5.2. EA is locally stable if
γiβii<S∗i<kiβii, | (5.4) |
(k1−β11S∗1)(k2−β22S∗2)>β12β21S∗1S∗2, | (5.5) |
βiiI∗i+βijI∗j+qi>σiSi,j=3−i, | (5.6) |
S∗1S∗2<r1r2σ1σ2, | (5.7) |
ri(βiiI∗i+βijI∗j−σiS∗i+qi)>γi(βiiI∗i+βijI∗j+σiI∗i), | (5.8) |
(rjγj(βjjI∗j+βjiI∗i−σjS∗j+qj)−βjjI∗j−βjiI∗i−σjI∗j)⋅(βiiI∗i+βijI∗j−σiS∗i+qi+ri)>σiS∗i(rjσjγjS∗j+σjI∗j),j=3−i, | (5.9) |
and
2∏m=1(rm(βmmI∗m+βmjI∗j−σmS∗m+qm)−γm(βmmI∗m+βmjI∗j+σmI∗m))>2∏m=1(rmσmS∗m+γmσmI∗m),j=3−m. | (5.10) |
Proof. Let us rearrange matrix J(EA) so that the characteristic polynomial of the new matrix remains the same. We get M∗=(M∗1 M∗20M∗3), where
M∗1=(−β11I∗1−β12I∗2−μ1−β11S∗1+γ10−β12S∗1β11I∗1+β12I∗2β11S∗1−k10β12S∗10−β21S∗2−β22I∗2−β21I∗1−μ2−β22S∗2+γ20β21S∗2β22I∗2+β21I∗1β22S∗2−k2) |
and
M∗3=(−β11I∗1−β12I∗2+σ1S∗1−q1γ1σ1S∗10β11I∗1+β12I∗2+σ1I∗1−r1σ1I∗10σ2S∗20−β22I∗2−β21I∗1+σ2S∗2−q2γ2σ2I∗20β22I∗2+β21I∗1+σ2I∗2−r2). |
The form of M∗2∈M4(R) is not needed for further computations.
We start by investigating matrix M∗1. To simplify computations, we define auxiliary notations:
ai=βiiI∗i+βijI∗j,ui=βiiS∗i−γi,ti=ki−βiiS∗i,zi=βijS∗i,wherej=3−i. | (5.11) |
Thanks to this simplification, matrix M∗1 reads
M∗1=(−a1−μ1−u10−z1a1−t10z10−z2−a2−μ2−u20z2a2−t2). |
The characteristic polynomial of M∗1 has the form
P1(λ):=λ4+c3λ3+c2λ2+c1λ+c0, |
where
c3=a1+a2+t1+t2+μ1+μ2,c2=(a1+μ1)(a2+μ2)+(t1+t2)(a1+a2+μ1+μ2)+a1u1+a2u2+t1t2−z1z2,c1=a1a2(t1+t2+u1+u2)+μ1μ2(t1+t2)+t1t2(a1+a2)+a1μ2(t1+t2+u1)+a2μ1(t1+t2+u2)+a1u1t2+a2u2t1+(μ1+μ2)(t1t2−z1z2),c0=a1a2(t1+u1)(t2+u2)+a1t2μ2(t1+u1)+a2t1μ1(t2+u2)+μ1μ2(t1t2−z1z2). |
Observe that if
ui>0,ti>0 | (5.12) |
and
t1t2−z1z2>0, | (5.13) |
then each coefficient of P1 is positive. Hence, from Descartes' rule of signs, we get that P4 has real negative roots or complex roots with negative real parts. Substituting definition (5.11) into inequalities (5.12) and (5.13) provides inequalities (5.4) and (5.5), respectively.
Let us focus now on matrix M∗3. After using notations:
ti=βiiI∗i+βijI∗j−σiS∗i+qi,ai=βiiI∗i+βijI∗j+σiI∗i,si=σiS∗i,yi=σiI∗i,wherej=3−i, | (5.14) |
we rewrite M∗3 as
M∗3=(−t1γ1s10a1−r1y10s20−t2γ2y20a2−r2). | (5.15) |
The characteristic polynomial of the matrix reads P3(λ):=λ4+c3λ3+c2λ2+c1λ+c0, where
c3=t1+t2+r1+r2>0,c2=(r1+t1)(r2+t2)−s1s2+r1t1−γ1a1+r2t2−γ2a2,c1=2∑j=1((tj+rj)(t3−jr3−j−γ3−ja3−j)−sj(r3−js3−j+γ3−jy3−j)),c0=(γ1a1−r1t1)(γ2a2−r2t2)−(r1s1+γ1y1)(r2s2+γ2y2). |
Let us investigate the signs of the coefficients of polynomial P3. Observe that if inequality (5.6) holds, then t1,t2>0, which yields c3>0. Conditions r1r2>s1s2 and riti>γiai, which can be written as inequalities (5.7) and (5.8), respectively, yield c2>0. See that c1>0 if (ti+ri)(tjrj−γjaj)>si(rjsj+γjyj) for j=3−i, which we transform to
(ti+ri)(rjγjtj−aj)>si(rjγjsj+yj). |
Using expressions from (5.14), we rewrite the above inequality as inequality (5.9). Condition c0>0 can be written as
2∏m=1(γmam−rmtm)>2∏m=1(rmsm+γmym) |
With (5.14), the above inequality transforms into inequality (5.10).
Now let us strengthen conditions from Theorem 5.2 providing the local stability of EA so that they have a more explicit form. Observe that the condition
S∗i<qiσi. | (5.16) |
yields fulfillment of inequality (5.6). Moreover, from definitions (2.2), clearly we have ri>qi. Hence, inequality (5.16) implies inequality (5.7).
Again relying on (2.2), we get ri>γi. Instead of inequality (5.8), it is therefore enough to investigate the inequality
ri(qi−σiS∗i)>γiσiI∗i. |
If inequality (5.16) holds, then the left-hand side of the above inequality is always positive. Using Eq (3.6), we transform this inequality into
S∗i<riqi−Ciγiσiαi+μiriσi−γiσiμiαi+μi. | (5.17) |
From the definition of ri, the denominator of the right-hand side of inequality (5.17) is positive if
(gi+ai+αi+μi)(μi+αi)+γiαi>0, |
which is always true. The positivity of the numerator of the right-hand side of inequality (5.17) is maintained if
Ci<riqi(μi+αi)γiσi. | (5.18) |
Now observe that since ri>γi, inequality (5.9) can be, under fulfillment of inequality (5.16), strengthened to
(qj−σj(S∗j+I∗j))⋅(βiiI∗i+βijI∗j−σiS∗i+qi+ri)>σiS∗i(rjσjγjS∗j+σjI∗j). | (5.19) |
If inequality (5.16) holds, then one must fulfill
S∗i+I∗i<qiσi. | (5.20) |
so that inequality (5.19) makes sense. Using Eq (3.6), we transform inequality (5.20) into
S∗i<qi(μi+αi)−Ciσiσiαi, | (5.21) |
which is reasonable if
Ci<qi(μi+αi)σi. | (5.22) |
Observe that inequality (5.22) is stricter than inequality (5.18). Rewriting inequality (5.19), we get
(βiiI∗i+βijI∗j)(qj−σj(S∗j+I∗j))+(qi+ri)qj>(rjγj−1)σ1σ2S∗1S∗2+(σiqjS∗i+(qi+ri)σj(S∗j+I∗j)). |
Using again Eq (3.6), we transform the above inequality into
−βijσjμ2j(μj+αj)2(S∗j)2−βiiμiμi+αi⋅σjμjμj+αjS∗1S∗2+(rjγj−1)σ1σ2S∗1S∗2+(βiiCiμi+αi⋅βijCjμj+αj)σjμjμj+αjS∗j−βijμjμj+αj(qj−σjCjμj+αj)S∗j+αj(qi+ri)μj+αjS∗j+(qj−σjCjμj+αj)(βii(Ci−μiS∗i)μi+αi+βijCjμj+αj)+σiqjS∗i+(qi+ri)σjCjμj+αj+(qi+ri)qj>0,j=3−i. | (5.23) |
Now we use the dependence ri>γi and transform inequality (5.10) into
2∏m=1(rm(qm−σmS∗m)−γmσmI∗m)>2∏m=1(rmσmS∗m+γmσmI∗m), |
which can be simplified to
σ1q1(S∗1+I∗1)+σ2q2(S∗2+I∗2)<1. | (5.24) |
Clearly, inequality (5.24) is stricter than inequalities (5.16) and (5.21).
Using Eq (3.6), we rewrite inequality (5.24) as
2∑j=1(σj(S∗jαj+Cj)qj(μj+αj))<1. | (5.25) |
We finally conclude that
Corollary 2. If (5.4), (5.5), (5.17), (5.22), (5.23) and (5.25), then EA is locally stable.
Let us treat the left-hand side of inequality (5.23) as a quadratic trinomial P(S∗j). If inequality (5.22) holds, then the condition Ci>σiS∗i suffices for the constant of P(S∗j) to be positive. Hence, the form of P(S∗j) implies that inequality (5.23) is true for 0<S∗j<S, where S is the positive zero of P(S∗j).
Now we provide the theorem indicating the conditions for the local stability of state EB:
Theorem 5.3. EB is locally stable if
ˉSi<kiβii, | (5.26) |
ˉS1ˉS2<r1r2β12β21, | (5.27) |
ri(σi(ˉJ1+ˉJ2)−βiiˉSi+ki)>gi(σi(ˉJ1+ˉJ2)+βiiˉJi), | (5.28) |
(rjgj(σj(ˉJ1+ˉJ2)−βjjˉSj+kj)−σj(ˉJ1+ˉJ2)−βjjˉJj)⋅(σi(ˉJ1+ˉJ2)−βiiˉSi+ki+ri)>β12β21ˉSi(rjgjˉSj+ˉJj),j=3−i, | (5.29) |
2∏m=1(gm(σm(ˉJ1+ˉJ2)+βmmˉJm)−rm(σm(ˉJ1+ˉJ2)−βmmˉSm+km))>2∏m=1(rmβmjˉSm+gmβmjˉJm),j=3−m. | (5.30) |
Proof. Similarly as in the proof of Theorem 5.2, we transform matrix J(EB) into MB=(ˉM1ˉM20ˉM3), where
ˉM1=(−μ1−σ1(ˉJ1+ˉJ2)−σ1ˉS1+g10−σ1ˉS1σ1(ˉJ1+ˉJ2)σ1ˉS1−q10σ1ˉS10−σ2ˉS2−μ2−σ2(ˉJ1+ˉJ2)−σ2ˉS2+g20σ2ˉS2σ2(ˉJ1+ˉJ2)σ2ˉS2−q2), |
ˉM3=(β11ˉS1−k1−σ1(ˉJ1+ˉJ2)g1β12ˉS10σ1(ˉJ1+ˉJ2)+β11ˉJ1−r1β12ˉJ10β21ˉS20β22ˉS2−k2+σ2(ˉJ1+ˉJ2)g2β21ˉJ20σ2(ˉJ1+ˉJ2)+β22ˉJ2−r2). |
We start from matrix ˉM1. After using notations:
ai=σi(ˉJ1+ˉJ2),si=σiˉSi,ti=qi−σiˉSi, | (5.31) |
we transform ˉM1 to
ˉM1=(−a1−μ1g1−s10−s1a1−t10s10−s2−a2−μ2g2−s20s2a2−t2). |
The characteristic polynomial of matrix ˉM1 reads P1(λ)=λ4+c3λ3+c2λ2+c1λ+c0, where
c3=a1+a2+t1+t2+γ1+γ2,c2=t1t2−s1s2+a1(s1−g1)+a2(s2−g2)+(t1+t2)(a1+μ1+a2+μ2)+(a1+μ1)(a2+μ2),c1=a1a2(s1+s2−g1−g2)+(μ1+μ2)(t1t2−s1s2)+a1(t2+μ2)(s1−g1)+a2(t1+μ1)(s2−g2),+a1t1(t2+μ2)+a2t2(t1+μ1)+(a1a2+μ1μ2)(t1+t2)+a1t2μ2+a2t1μ1,c0=(t1t2−s1s2)(μ1μ2+a1a2)+a1t2(a2+μ2)(s2−g2)+t1t2(a1μ2+a2μ1)+a2t1(a1+μ1)(s1−g1)+a1a2(s1−g1)(s2−g2)+a1a2s1s2. |
Observe that if
s1>g1,s2>g2, | (5.32) |
and
t1t2>s1s2 | (5.33) |
then c2,c1,c0>0. Hence, from Descartes' rule of signs, we get that P1 has real negative roots or complex roots with negative real parts.
Using definitions (5.31), we rewrite inequality (5.32) as inequality (5.6) and inequality (5.33) as
σ1q1ˉS1+σ2q2ˉS2<1. | (5.34) |
Now we focus on matrix ˉM3. With the use of expressions,
ti=σi(ˉJ1+ˉJ2)−βiiˉSi+ki,ai=σi(ˉJ1+ˉJ2)+βiiˉJi,si=βijˉSi,yi=βijˉJi,wherej=3−i, | (5.35) |
we rewrite ˉM3 as
ˉM3=(−t1g1s10a1−r1y10s20−t2g2y20a2−r2), |
which has a similar form as matrix M∗3 from (5.15). This similarity allows us to apply reasoning for M∗3 to ˉM3. Analogically to conditions (5.6)–(5.10), we obtain inequalities (5.26)–(5.30).
Similarly as for Theorem 5.2, let us strengthen conditions from Theorem 5.3 providing the local stability of EB. Since ri>gi, we replace inequality (5.28) by
ri(ki−βiiˉSi)>giβiiˉJi, | (5.36) |
which obviously requires fulfillment of inequality (5.26). Using Eq (3.8), we express the above inequality as
ˉSi<ri(μi+αi)ki−Ciβiigiβii((ai+γi+αi+μi)μi+riαi), | (5.37) |
under fulfillment of
Ci<ri(μi+αi)kiβiigi. | (5.38) |
Again using the dependence ri>gi, we simplify inequality (5.29) to
(rjgj(kj−βjjˉSj)−βjjˉJj)(σi(ˉJ1+ˉJ2)−βiiˉSi+ki+ri)>β12β21ˉSi(rjgjˉSj+ˉJj),j=3−i. | (5.39) |
Since inequality (5.26) holds, it is enough that inequality (5.36) holds so that inequality (5.39) makes sense.
Inequality (5.30) can be strengthened by
2∏m=1(gmβmmJm+rm(βmmˉSm−km))>2∏m=1(rmβmjˉSm+gmβmjˉJm), |
which can be expressed as
(β11β22−β12β21)(g1ˉJ1+r1ˉS1)(g2ˉJ2+r2ˉS2)+β11k2r2(r1ˉS1−g1ˉJ1)+β22k2r1(r2ˉS2−g2ˉJ2)+r1r2k1k2>0. | (5.40) |
The above inequality is always true if
β11β22>β12β21 | (5.41) |
and
riˉSi>giˉJi. | (5.42) |
Using Eq (3.8), we rewrite inequality (5.42) as
ˉSi>Cigiμigi+μiri+αiri. | (5.43) |
Let us compare inequalities (5.26) and (5.27). Observe that ri>ki. Moreover, if inequality (5.41) holds, then inequality (5.26) is stronger than inequality (5.27).
Finally, we conclude that
Corollary 3. If inequalities (5.26), (5.37), (5.38), (5.39), (5.40), (5.41), and (5.43) hold, then EB is locally stable.
In Subsection 3.2, we provided only a slight analysis of the existence of the endemic stationary state EE, with two diseases present. We are therefore not certain if this state exists. Furthermore, the complexity of the proper Jacobian matrix does not allow us to obtain the explicit conditions for local stability of such a postulated equilibrium. However, the conditions from Theorems 5.2 and 5.3 restrict a set of parameters' values guaranteeing the local stability of existing states EA and EB. Such restriction suggests that there should be ranges of the values for the EE local stability under its existence. Indicating these ranges is difficult, even numerically, because of the system's intricacy. For this reason, for each parameter, we only give specific values that yield the desirable local stability. We rely on the values from [10] that concern TB and COVID-19. In our system, these diseases correspond to diseases A and B, respectively. Since paper [10] relates to co-infection dynamics in a homogeneous population, we arbitrarily choose the values of incompatible parameters from our system. These values are chosen so that we reach the EE local stability. In Table 1, one can find the taken numbers.
Symbol | Value |
C1 | 130 |
C2 | 10 |
β11 | 2⋅10−6 |
β12 | 8⋅10−6 |
β21 | 3⋅10−6 |
β22 | 6.5⋅10−6 |
σ1, σ2 | 5.5⋅10−6 |
γ1, γ2 | 0.02 |
μ1, μ2 | 159.365 |
g1, g2 | 0.015 |
α1,α2 | 0.004 |
a1, a2 | 0.0018 |
We illustrate the local stability of EE on the plots showing the dependence of the system's solution on time for each particular variable. For the illustration, we use the Matlab software, which provides a built-in ode45 function. This function numerically solves a given differential equation system for a specified initial condition [27]. For the simulation, we take the parameters' values from Table 1 and the arbitrarily chosen initial condition
(S1(0),I1(0),J1(0),K1(0),S2(0),I2(0),J2(0),K2(0))=(5000,100,300,10,500,60,70,5). |
Figures 2–3 depict the result of the simulation. For the figures' transparency, we show plots for the infected variables for each subpopulation and the non-infected variables in separate picture graphs. The obtained figures suggest the existence of the stationary state Ee that is locally stable for the parameter values from Table 1.
Now for the illustrated example of epidemic, we depict the relative sizes of the infections for time t that we define by ratios:
R1(t):=I1(t)+K1(t)J1(t)+K1(t),R2(t):=I2(t)+K2(t)J2(t)+K2(t),R(t):=I1(t)+I2(t)+K1(t)+K2(t)J1(t)+J2(t)+K1(t)+K2(t). |
These ratios correspond to LS, HS, and the whole population, respectively, and in our case represent the number of TB-infected individuals relative to the number of COVID-infected ones. Figure 4 shows the dependence of the relative sizes on time.
For the last point of the simulation timescale, i.e., ˉt=1600, we get R1(ˉt)=0.1176 and R2(ˉt)=0.3432. Plots from the figure suggest the convergence of each relative size. We therefore state that for the stabilized co-infection epidemic, for one TB-infected person, there are approximately nine and three COVID-infected people in LS and HS, respectively.
In this paper, we proposed and analyzed the continuous-time model (2.1) describing co-infection in a heterogeneous population, in which we distinguish two subpopulations. These subpopulations, low-risk LS and high-risk HS, differ in the risk of getting infected by any of two diseases, called disease A (DA) and disease B (DA). The values of the parameters for every subpopulation are different, which guarantees complete population heterogeneity. System (2.1) has three stationary states: disease-free (Edf), with sole DA or DB (EA and EB). We also suspect that the endemic state, with two diseases present, exists, but we did not manage to prove it because of complicated computations. State Edf exists unconditionally, while provided conditions determine the existence of EA and EB. For state Ee, we only gave insight into its existence because of the complexity of the computations. For system (2.1), we computed the basic reproduction number R0. This number is the maximum of two terms, whose forms depend on parameters corresponding to the particular sole infection. Later, we investigated the local stability of the stationary state. State Edf is locally stable if R0<1, which is expected. Analysis of the local stability for EA and EB provided the list of conditions. Importantly, the parameters from both diseases affect the local stability of both states.
The proposed model expands the system from [24], where we investigated the epidemic dynamics of one disease in heterogeneous populations. In that system, there are only two stationary states: the disease-free state and the endemic state, which is a counterpart of state EA of system (2.1). The results for their local stabilities are analogical to those for state Edf and EA in this paper.
The next step of our work will be an analysis of the proposed model with some assumptions simplifying this form. We hope to obtain the endemic state of the simplified model and get explicit results concerning its local stability.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
The author declares there is no conflict of interest.
[1] | The Lancet.A world of 7 billion people. Lancet (2011) 378: 1527. https://doi.org/10.1016/S0140-6736(11)61658-9 |
[2] | Department of Economic and Social AffairsWorld population to reach 8 billion on 15 November 2022 (2022). Available from: https://www.un.org/en/desa/world-population-reach-8-billion-15-november-2022. |
[3] | World Health OrganizationUniversal health coverage (2021). Available from: https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc). |
[4] |
Odoch WD, Senkubuge F, Masese AB, et al. (2023) A critical review of literature on health financing reforms in Uganda-progress, challenges and opportunities for achieving UHC. Afr Health Sci 23: 736-746. https://doi.org/10.4314/ahs.v23i1.78 ![]() |
[5] | World Health OrganizationGlobal oral health status report: Towards universal health coverage for oral health by 2030 (2022). Available from: https://www.paho.org/en/documents/global-oral-health-status-report-towards-universal-health-coverage-oral-health-2030 |
[6] | (2022) Assistant Secretary for Public Affairs (ASPA)Ahead of open enrollment, new HHS Report shows major gains in marketplace enrollment among Black and Latino populations last year. USA: HHS Press Office. Available from: https://www.hhs.gov/about/news/2022/10/25/ahead-of-open-enrollment-new-hhs-report-shows-major-gains-in-marketplace-enrollment-among-black-and-latino-populations-last-year.html |
[7] |
Tan X, Liu X, Shao H (2017) Healthy China 2030: A vision for health care. Value Health Reg Issues 12: 112-114. https://doi.org/10.1016/j.vhri.2017.04.001 ![]() |
[8] |
Angell BJ, Prinja S, Gupt A, et al. (2019) The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance. PLoS Med 16: e1002759. https://doi.org/10.1371/journal.pmed.1002759 ![]() |
[9] | General Assembly.Resolution adopted by the general assembly on 10 October 2019-A/RES/74/2 “Political declaration of the high-level meeting on universal health coverage”. 74th United Nations GA Session (2022) . Available from: https://documents-dds-ny.un.org/doc/UNDOC/GEN/N19/311/84/PDF/N1931184.pdf?OpenElement |
[10] |
Kumar R, Pal R (2018) India achieves WHO recommended doctor population ratio: A call for paradigm shift in public health discourse!. J Family Med Prim Care 7: 841-844. https://doi.org/10.4103/jfmpc.jfmpc_218_18 ![]() |
[11] | Schwartz E (2022) The global health care worker shortage: 10 Numbers to note. Project Hope . Available from: https://www.projecthope.org/the-global-health-worker-shortage-10-numbers-to-note/04/2022/ |
[12] |
Boniol M, Kunjumen T, Nair TS, et al. (2022) The global health workforce stock and distribution in 2020 and 2030: a threat to equity and ‘universal’ health coverage?. BMJ Glob Health 7: e009316. https://doi.org/10.1136/bmjgh-2022-009316 ![]() |
[13] |
Owens B (2018) If Canada needs more doctors, why hasn't medical school enrolment increased?. CMAJ 190: E1266-E1267. https://doi.org/10.1503/cmaj.109-5649 ![]() |
[14] |
McGrail MR, O'Sullivan BG (2021) Increasing doctors working in specific rural regions through selection from and training in the same region: National evidence from Australia. Hum Resour Health 19: 132. https://doi.org/10.1186/s12960-021-00678-w ![]() |
[15] |
Adovor E, Czaika M, Docquier F, et al. (2021) Medical brain drain: How many, where and why?. J Health Econ 76: 102409. https://doi.org/10.1016/j.jhealeco.2020.102409 ![]() |
[16] |
Newman C (2014) Time to address gender discrimination and inequality in the health workforce. Hum Resour Health 12: 25. https://doi.org/10.1186/1478-4491-12-25 ![]() |
[17] |
Hay K, McDougal L, Percival V, et al. (2019) Disrupting gender norms in health systems: making the case for change. Lancet 393: 2535-2549. https://doi.org/10.1016/S0140-6736(19)30648-8 ![]() |
[18] |
Wu LT, Low MM, Tan KK, et al. (2015) Why not nursing? A systematic review of factors influencing career choice among healthcare students. Int Nurs Rev 62: 547-562. https://doi.org/10.1111/inr.12220 ![]() |
[19] |
Hasebrook J, Hahnenkamp K, Buhre WFFA, et al. (2017) Medicine goes female: Protocol for improving career options of females and working conditions for researching physicians in clinical medical research by organizational transformation and participatory design. JMIR Res Protoc 6: e152. https://doi.org/10.2196/resprot.7632 ![]() |
[20] |
Murthy VH (2022) Confronting health worker burnout and well-being. N Engl J Med 387: 577-579. https://doi.org/10.1056/NEJMp2207252 ![]() |
[21] |
Sinsky CA, Brown RL, Stillman MJ, et al. (2021) COVID-related stress and work intentions in a sample of US health care workers. Mayo Clin Proc Innov Qual Outcomes 5: 1165-1173. https://doi.org/10.1016/j.mayocpiqo.2021.08.007 ![]() |
[22] | World Health OrganizationNoncommunicable diseases (2022). Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases |
[23] | World Health OrganizationPreventing chronic diseases: A vital investment: WHO global report (2005). Available from: https://apps.who.int/iris/handle/10665/43314 |
[24] |
Mirelman AJ, Rose S, Khan JA, et al. (2016) The relationship between non-communicable disease occurrence and poverty-evidence from demographic surveillance in Matlab, Bangladesh. Health Policy Plan 31: 785-792. https://doi.org/10.1093/heapol/czv134 ![]() |
[25] | Shiferaw F, Letebo M, Feleke Y, et al. (2019) Non-communicable diseases in Ethiopia: Policy and strategy gaps in the reduction of behavioral risk factors. Ethiop J Health Development 33: 260-267. |
[26] | Albelbeisi AH, Albelbeisi A, El Bilbeisi AH, et al. (2021) Public sector capacity to prevent and control of noncommunicable diseases in twelve low- and middle-income countries based on WHO-PEN standards: A systematic review. Health Serv Insights 14: 1178632920986233. https://doi.org/10.1177/1178632920986233 |
[27] |
Tripathy JP (2018) Research priorities in non-communicable diseases in developing countries: Time to go beyond prevalence studies. Public Health Action 8: 98-99. https://doi.org/10.5588/pha.18.0023 ![]() |
[28] |
Mendis S, Johnston SC, Fan W, et al. (2010) Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: A cluster-randomized trial. Bull World Health Organ 88: 412-419. https://doi.org/10.2471/BLT.08.062364 ![]() |
[29] | Zhao S, Zhang Y, Xiao AY, et al. (2023) Key factors associated with quality of postnatal care: A pooled analysis of 23 countries. E Clinical Medicine 62: 102090. https://doi.org/10.1016/j.eclinm.2023.102090 |
[30] |
Fritz M, Fromell H (2022) How to dampen the surge of non-communicable diseases in Southeast Asia: insights from a systematic review and meta-analysis. Health Policy Plan 37: 152-167. https://doi.org/10.1093/heapol/czab138 ![]() |
[31] |
Santos JA, Tekle D, Rosewarne E, et al. (2021) A systematic review of salt reduction initiatives around the world: A midterm evaluation of progress towards the 2025 global non-communicable diseases salt reduction target. Adv Nutr 12: 1768-1780. https://doi.org/10.1093/advances/nmab008 ![]() |
[32] | World Health OrganizationWHO launches Signature Initiative to reduce cardiovascular disease through salt reduction (2022). Available from: https://www.who.int/europe/news-room/events/item/2022/12/09/default-calendar/who-launches-signature-initiative-to-reduce-cardiovascular-disease-through-salt-reduction |
[33] |
Mohammed S, Afaya A, Abukari AS (2023) Reading, singing, and storytelling: The impact of caregiver-child interaction and child access to books and preschool on early childhood development in Ghana. Sci Rep 13: 13751. https://doi.org/10.1038/s41598-023-38439-5 ![]() |
[34] |
Eriksson MK, Hagberg L, Lindholm L, et al. (2010) Quality of life and cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care. Arch Intern Med 170: 1470-1479. https://doi.org/10.1001/archinternmed.2010.301 ![]() |
[35] |
Romé A, Persson U, Ekdahl C, et al. (2009) Physical activity on prescription (PAP): costs and consequences of a randomized, controlled trial in primary healthcare. Scand J Prim Health Care 27: 216-222. https://doi.org/10.3109/02813430903438734 ![]() |
[36] | World Health OrganizationAgeing and health (2022). Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health |
[37] |
Cheng X, Yang Y, Schwebel DC, et al. (2020) Population ageing and mortality during 1990–2017: A global decomposition analysis. PLoS Med 17: e1003138. https://doi.org/10.1371/journal.pmed.1003138 ![]() |
[38] |
Tipirneni R, Solway E, Malani P, et al. (2020) Health Insurance Affordability Concerns and Health Care Avoidance Among US Adults Approaching Retirement. JAMA Netw Open 3: e1920647. https://doi.org/10.1001/jamanetworkopen.2019.20647 ![]() |
[39] |
Gabrani J, Schindler C, Wyss K (2022) Out of pocket payments and access to NCD medication in two regions in Albania. PLoS One 17: e0272221. https://doi.org/10.1371/journal.pone.0272221 ![]() |
[40] |
Hock H, Weil DN (2012) On the dynamics of the age structure, dependency, and consumption. J Popul Econ 25: 10.1007/s00148-011-0372-x. https://doi.org/10.1007/s00148-011-0372-x ![]() |
[41] |
Malik C, Khanna S, Jain Y, et al. (2021) Geriatric population in India: Demography, vulnerabilities, and healthcare challenges. J Family Med Prim Care 10: 72-76. https://doi.org/10.4103/jfmpc.jfmpc_1794_20 ![]() |
[42] |
Murdaca G, Orsi A, Spanò F, et al. (2014) Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev 13: 75-84. https://doi.org/10.1016/j.autrev.2013.07.007 ![]() |
[43] |
Murdaca G, Orsi A, Spanò F, et al. (2016) Vaccine-preventable infections in Systemic Lupus Erythematosus. Hum Vaccin Immunother 12: 632-643. Https://doi.org/10.1080/21645515.2015.1107685 ![]() |
[44] |
Fulmer T, Reuben DB, Auerbach J, et al. (2021) Actualizing better health and health care for older adults. Health Aff (Millwood) 40: 219-225. https://doi.org/10.1377/hlthaff.2020.01470 ![]() |
[45] | Indriani D (2020) Efektivitas Implementasi Badan Penyelenggaraan Jaminan Sosial (BPJS) Serta Dampaknya Terhadap Kesehatan Dan Ekonomi Masyarakat Tahun 2009–2013 Dan 2015–2019. J Ris Mhs 1: 76-85. https://doi.org/10.23969/brainy.v1i1.11 |
[46] |
Combi C, Pozzani G, Pozzi G (2016) Telemedicine for developing countries. A survey and some design issues. Appl Clin Inform 7: 1025-1050. https://doi.org/10.4338/ACI-2016-06-R-0089 ![]() |
[47] | World Health OrganizationTelemedicine has clear benefits for patients in European countries, new study shows. Europe World Health Organization (2022). Available from: https://www.who.int/europe/news/item/31-10-2022-telemedicine-has-clear-benefits-for-patients-in-european-countries--new-study-shows |
[48] |
Fernandez-Lazaro CI, García-González JM, Adams DP, et al. (2019) Adherence to treatment and related factors among patients with chronic conditions in primary care: A cross-sectional study. BMC Fam Pract 20: 132. https://doi.org/10.1186/s12875-019-1019-3 ![]() |
[49] |
Tkatch R, Musich S, MacLeod S, et al. (2016) Population health management for older adults: Review of interventions for promoting successful aging across the health continuum. Gerontol Geriatr Med 2: 2333721416667877. https://doi.org/10.1177/2333721416667877 ![]() |
[50] |
Macinko J, Cristina Drumond Andrade F, Bof de Andrade F, et al. (2020) Universal health coverage: Are older adults being left behind? Evidence from aging cohorts in twenty-three countries. Health Aff (Millwood) 39: 1951-1960. https://doi.org/10.1377/hlthaff.2019.01570 ![]() |
[51] |
Okamoto S, Komamura K (2022) Towards universal health coverage in the context of population ageing: a narrative review on the implications from the long-term care system in Japan. Arch Public Health 80: 210. https://doi.org/10.1186/s13690-022-00970-8 ![]() |
[52] |
Jacques E, Suuronen EJ (2020) The progression of regenerative medicine and its impact on therapy translation. Clin Transl Sci 13: 440-450. https://doi.org/10.1111/cts.12736 ![]() |
[53] |
Mao AS, Mooney DJ (2015) Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci USA 112: 14452-14459. https://doi.org/10.1073/pnas.1508520112 ![]() |
[54] |
Lovell-Badge R, Anthony E, Barker RA, et al. (2021) ISSCR Guidelines for stem cell research and clinical translation: The 2021 update. Stem Cell Reports 16: 1398-1408. https://doi.org/10.1016/j.stemcr.2021.05.012 ![]() |
[55] |
Russa AD (2019) Stem cells: Prospects and potential applications in Tanzania: A review. Tanzan J Health Res 21: 1-8. https://doi.org/10.4314/thrb.v21i2.8 ![]() |
[56] |
Ricci F (2012) Social implications of malaria and their relationships with poverty. Mediterr J Hematol Infect Dis 4: e2012048. https://doi.org/10.4084/MJHID.2012.048 ![]() |
[57] |
Nguyen-Tien T, Do DC, Le XL, et al. (2021) Risk factors of dengue fever in an urban area in Vietnam: A case-control study. BMC Public Health 21: 664. https://doi.org/10.1186/s12889-021-10687-y ![]() |
[58] | Neiderud CJ (2015) How urbanization affects the epidemiology of emerging infectious diseases. Infect Ecol Epidemiol 5: 27060. https://doi.org/10.3402/iee.v5.27060 |
[59] | Carballo M, Maclean EC, Gudumac I, et al. (2016) Hepatitis C and migration: A public health challenge. J Fam Med 3: 1065. |
[60] | World Economic Forum (WEF)The art and science of eliminating Hepatitis: Egypt's experience (2022). Available from: https://www.weforum.org/whitepapers/the-art-and-science-of-eliminating-hepatitis-egypt-s-experience/ |
[61] |
Boretti A, Rosa L (2019) Reassessing the projections of the World Water Development Report. NPJ Clean Water 2: 15. https://doi.org/10.1038/s41545-019-0039-9 ![]() |
[62] |
Tarrass F, Benjelloun M (2012) The effects of water shortages on health and human development. Perspect Public Health 132: 240-244. https://doi.org/10.1177/1757913910391040 ![]() |
[63] |
Ahmed T, Zounemat-Kermani M, Scholz M (2020) Climate change, water quality and water-related challenges: A review with focus on Pakistan. Int J Environ Res Public Health 17: 8518. https://doi.org/10.3390/ijerph17228518 ![]() |
[64] |
Strunz EC, Addiss DG, Stocks ME, et al. (2014) Water, sanitation, hygiene, and soil-transmitted helminth infection: A systematic review and meta-analysis. PLoS Med 11: e1001620. https://doi.org/10.1371/journal.pmed.1001620 ![]() |
[65] | Garn JV, Wilkers JL, Meehan AA, et al. (2022) Interventions to improve water, sanitation, and hygiene for preventing soil-transmitted helminth infection. Cochrane Database Syst Rev 6: CD012199. https://doi.org/10.1002/14651858.CD012199.pub2 |
[66] |
van Dijk M, Morley T, Rau ML, et al. (2021) A meta-analysis of projected global food demand and population at risk of hunger for the period 2010–2050. Nat Food 2: 494-501. https://doi.org/10.1038/s43016-021-00322-9 ![]() |
[67] | Cartín-Rojas A (2012) Transboundary animal diseases and international trade. International Trade from Economic and Policy Perspective [online] . London: IntechOpen. https://doi.org/10.5772/48151 |
[68] | WHO Global Centre for Traditional MedicineCatalysing ancient wisdom and modern science for the health of people and the planet (2022). Available from: https://www.who.int/initiatives/who-global-centre-for-traditional-medicine |
[69] | Madamombe I (2006) Traditional healers boost primary health care. Africa Renewal (United Nations) . Available from: https://www.un.org/africarenewal/magazine/january-2006/traditional-healers-boost-primary-health-care |
[70] | Health in HarmonyImpact Report 2021 (2022). Available from: https://healthinharmony.org/wp-content/uploads/2021-HIH-Impact-Report_Final_small.pdf |
Symbol | Value |
C1 | 130 |
C2 | 10 |
β11 | 2⋅10−6 |
β12 | 8⋅10−6 |
β21 | 3⋅10−6 |
β22 | 6.5⋅10−6 |
σ1, σ2 | 5.5⋅10−6 |
γ1, γ2 | 0.02 |
μ1, μ2 | 159.365 |
g1, g2 | 0.015 |
α1,α2 | 0.004 |
a1, a2 | 0.0018 |